Evidence map›Paper›PMID 35873153›Full record

ReviewFrontiers in cellular and infection microbiology2022

Advancing Key Gaps in the Knowledge of

Iris Aparici Herraiz, Hugo R Caires, Óscar Castillo-Fernández, Núria Sima, Lourdes Méndez-Mora, Ruth M Risueño, Jetsumon Sattabongkot, Wanlapa Roobsoong, Aurora Hernández-Machado, Carmen Fernandez-Becerra and 2 more

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Iris Aparici HerraizBarcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Hugo R Cairesi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Óscar Castillo-FernándezBarcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Núria SimaBarcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Lourdes Méndez-MoraDepartment of Condensed Matter Physics, University of Barcelona (UB), Barcelona, Spain.
Ruth M RisueñoJosep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.
Jetsumon SattabongkotMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Wanlapa RoobsoongMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Aurora Hernández-MachadoInstitute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain.
Carmen Fernandez-BecerraBarcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Cristina C Barriasi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Hernando A Del PortilloBarcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntimalarialsMalariaMalaria, VivaxAnimalsBone MarrowDisease Models, AnimalHumansMicePlasmodium vivaxAntimalarialshumanized mouseKey gaps in the knowledgemodelsorgans-on-a-chipPlasmodium vivax

Identifiers

PMID35873153
PMCPMC9302440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.